Katarzyna Kotulska

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications

Beyond seizures: proceedings of the ERN EpiCARE working group 18 on developmental and epileptic encephalopathies.

Beyond seizures: proceedings of the ERN EpiCARE working group 18 on developmental and epileptic encephalopathies.

Journal: Epilepsy & behavior : E&B
Published: February 28, 2026

Hemispheric surgery for hemimegalencephaly and hemispheric cortical dysplasia in infants below 12 months of age-A single-center experience.

Hemispheric surgery for hemimegalencephaly and hemispheric cortical dysplasia in infants below 12 months of age-A single-center experience.

Journal: Epilepsia
Published: February 09, 2026

Pediatric tuberous sclerosis complex: assessment of multidisciplinary follow-up in an expert center.

Pediatric tuberous sclerosis complex: assessment of multidisciplinary follow-up in an expert center.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: November 03, 2025

Areas of research priorities in epilepsy: A position paper of the European Reference Network for Rare and Complex Epilepsies, EpiCARE.

Areas of research priorities in epilepsy: A position paper of the European Reference Network for Rare and Complex Epilepsies, EpiCARE.

Journal: Epilepsia open
Published: July 22, 2025

Trifluoperazine, an Antipsychotic Drug, Inhibits Viability of Cells Derived From SEGA and Cortical Tubers Cultured In Vitro.

Trifluoperazine, an Antipsychotic Drug, Inhibits Viability of Cells Derived From SEGA and Cortical Tubers Cultured In Vitro.

Journal: Journal of neurochemistry
Published: March 18, 2025

Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study.

Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study.

Journal: Journal of neurology
Published: October 26, 2024

Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex.

Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex.

Journal: Brain & development
Published: October 06, 2024

Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex.

Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex.

Journal: Epilepsia
Published: August 16, 2024

Methodological insights from the EPISTOP trial to designing clinical trials in rare diseases-A secondary analysis of a randomized clinical trial.

Methodological insights from the EPISTOP trial to designing clinical trials in rare diseases-A secondary analysis of a randomized clinical trial.

Journal: PloS one
Published: June 21, 2024

Corrigendum to "Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy" [Eur. J. Paediatr. Neurol. 47 (2023) 25-34].

Corrigendum to "Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy" [Eur. J. Paediatr. Neurol. 47 (2023) 25-34].

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: May 18, 2024

Immunological markers of drug resistant epilepsy and its response to immunomodulatory therapy with ACTH in children.

Immunological markers of drug resistant epilepsy and its response to immunomodulatory therapy with ACTH in children.

Journal: Folia neuropathologica
Published: January 04, 2024

Commentary Regarding the Results of the PREVeNT and EPISTOP Trials.

Commentary Regarding the Results of the PREVeNT and EPISTOP Trials.

Journal: Annals of neurology
Published: October 15, 2023
Showing 1-12 of 120

Last Updated: 09/26/2026